{
  "nctId": "NCT03297346",
  "briefTitle": "Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer",
  "officialTitle": "Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer (EARLY HEART Study) in the Frame of the Implications of MEDIcal Low Dose RADiation Exposure (MEDIRAD) European Project",
  "protocolDocument": {
    "nctId": "NCT03297346",
    "filename": "Prot_SAP_ICF_000.pdf",
    "label": "Study Protocol, Statistical Analysis Plan, and Informed Consent Form",
    "date": "2017-07-05",
    "uploadDate": "2017-09-28T03:09",
    "size": 1334536,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03297346/document/Prot_SAP_ICF_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": true
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 250,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2017-09-01",
    "completionDate": "2021-05-31",
    "primaryCompletionDate": "2020-10-01",
    "firstSubmitDate": "2017-09-21",
    "firstPostDate": "2017-09-29"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Female unilateral breast cancer patients\n* Treated with primary breast conserving surgery for stage I-III invasive adenocarcinoma of the breast or ductal carcinoma in situ (DCIS)\n* Age between 40-75 years at time of start radiotherapy\n* World Health Organisation (WHO) performance status 0-1\n* Planned for radiotherapy alone to the breast with or without the lymph node areas\n* Radiotherapy based on planning-CT scan using either three dimensional conformal radiation therapy (3D-CRT), Intensity-modulated radiotherapy (IMRT), or Volumetric Arc Therapy (VMAT/RapidArc)\n* Written Informed consent\n\nExclusion Criteria:\n\n* Male breast cancer patients\n* Neoadjuvant or adjuvant chemotherapy\n* M1 disease (metastatic breast cancer)\n* Medical history of coronary artery disease and/or myocardial infarction and/or atrial fibrillation\n* Previous thoracic or mediastinal radiation\n* Contraindications to injection of iodinated contrast such as allergy or renal failure\n* Pregnancy or lactation\n* Atrial fibrillation detected during electrocardiogram before radiotherapy\n* Abnormal echocardiography before radiotherapy defined as: Left Ventricular Ejection Fraction\\<50%; longitudinal strain â‰¤ -16%; longitudinal strain rate \\<-1%, and/or abnormal wall motion\n* Presence of myocardial infarction detected during MRI before radiotherapy\n* CT or MRI results before radiotherapy requiring revascularisation",
    "healthyVolunteers": true,
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "maximumAge": "75 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Number of patients with decreased myocardial function assessed by echocardiography",
        "description": "Number of patients with an increased of at least 2.5% in the Global Longitudinal Strain (GLS) between baseline and 2 years after radiotherapy",
        "timeFrame": "2 years after radiotherapy (baseline measurements performed before radiotherapy)"
      }
    ],
    "secondary": [
      {
        "measure": "Changes in myocardial function measurements assessed by echocardiography",
        "description": "Increase of the segmental strain measurements (unit of measures:%)",
        "timeFrame": "6 months and 2 years after radiotherapy (baseline measurements performed before radiotherapy)"
      },
      {
        "measure": "Anatomical changes in coronary arteries assessed by cardiac CT",
        "description": "Increase of the number of coronary segments containing any plaque or increase of the calcium score",
        "timeFrame": "2 years after radiotherapy (baseline measurements performed before radiotherapy)"
      },
      {
        "measure": "Myocardial tissue abnormalities assessed by cardiac MRI",
        "description": "Increase of the native mean myocardial T1 mapping value",
        "timeFrame": "6 months and 2 years after radiotherapy (baseline measurements performed before radiotherapy)"
      },
      {
        "measure": "Changes in circulating biomarkers measurements",
        "description": "Significant increase or decrease in the following biomarkers:\n\nclassical biomarkers of cardiac injury (C-reactive protein, Troponin I, Troponin T, B-type natriuretic peptide (BNP), N-terminal pro-brain natriuretic peptide (NT-Pro BNP), beta2-Microglobulin, Galectin 3); Inflammatory cytokines; biomarkers of endothelial activation and dysfunction; Microparticles; MicroRNAs; circulating DNA methylation",
        "timeFrame": "at the end of radiotherapy (through radiotherapy completion, an average of 5 weeks after starting date of radiotherapy), 6 months and 2 years after radiotherapy (baseline measurements performed before radiotherapy)"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 4,
      "otherCount": 0,
      "totalCount": 5
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 34,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:54.793Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}